Precipio Presents Poster on HemeScreen® Study at Association of Molecular Pathology (AMP) 2022 Annual ConferenceGlobeNewsWire • 11/07/22
Precipio Signs Agreement with Another Major US Healthcare Distributor for HemeScreen™GlobeNewsWire • 09/15/22
Sharon Robins Joins Precipio's Products Division as Senior Director of Laboratory & Hospital SalesGlobeNewsWire • 08/24/22
Precipio, Inc. (PRPO) CEO Ilan Danieli on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/16/22
Toni-Ann Mills Joins Precipio's Products Division to Lead Channel Partner Training, Learning & DevelopmentGlobeNewsWire • 08/10/22
Precipio requests that all Stockholders that have not yet voted, proceed to cast their voteGlobeNewsWire • 06/14/22
Precipio Receives CE-IVD Certification to Market Multiple HemeScreen® Panels in EuropeGlobeNewsWire • 05/24/22
Precipio customer American Oncology Network (AON) selected to present HemeScreen® technology case study at Industry leading clinical laboratory conferenceGlobeNewsWire • 04/26/22
Precipio, Inc. (PRPO) CEO Ilan Danieli on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 04/04/22
Precipio Inc. Announces the Resignation of its Chief Financial Officer and Appointment of Interim CFOGlobeNewsWire • 03/21/22
Precipio Releases Year-End 2021 Preliminary Unaudited Results and Outlook for 2022GlobeNewsWire • 02/24/22
Precipio, Inc. (PRPO) CEO Ilan Danieli on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/16/21
Precipio, Inc. (PRPO) CEO Ilan Danieli on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/27/21
American Oncology Network Partners with Precipio to Bring HemeScreen® into AON's LaboratoryGlobeNewsWire • 08/26/21